INFORM RSV

• Research type

  Research Study

• Full title

  International, multi-centre, observational study to determine the molecular heterogeneity of RSV in children

• IRAS ID

  236132

• Contact name

  Mark Esser

• Contact email

  esserm@medimmune.com

• Sponsor organisation

  MedImmune LLC

• Duration of Study in the UK

  4 years, 3 months, 18 days

• Research summary

  Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory infections in infants worldwide, causing 3.4 million hospitalisations and up to 199000 deaths per year. Current treatment is largely supportive.

  The INFORM RSV study will collect RSV samples from a global population of children aged <5 years. The samples will be used to identify and sequence the different virus subtypes to improve our understanding of RSV and potentially guide new therapies.

• REC name

  East Midlands - Leicester Central Research Ethics Committee

• REC reference

  17/EM/0469

• Date of REC Opinion

  4 Jan 2018

• REC opinion

  Further Information Favourable Opinion